EUVIMEDEUVIMED entdecken
Crossref

Chlorogenic Acid Inhibited Epithelial–Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy

Xiaojuan Mao, Xiaomin Xie, Jun Ma, Yulin Wei, Zhiyong Huang, Tiantian Wang, Jiaqi Zhu, Yue Wang, Huan Zhao, Jiajia Hua

Biological and Pharmaceutical Bulletin · 2023

DOI: 10.1248/bpb.b23-00071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Xiaojuan Mao und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Sixth People's Hospital of Nantong. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chlorogenic acid (CGA), derived from dicotyledons and ferns, has been demonstrated with anti-inflammatory, anti-bacterial, and free radical-scavenging effects and can be used to treat pulmonary fibrosis (PF). However, the specific mechanism by which CGA treats PF needs to be further investigated. In this study, in vivo experiment was firstly performed to evaluate the effects of CGA on epithelial-mesenchymal transition (EMT) and autophagy in bleomycin (BLM)-induced PF mice. Then, the effects of CGA on EMT and autophagy was assessed using transforming growth factor beta (TGF-β) 1-induced EMT model in vitro. Furthermore, autophagy inhibitor (3-methyladenine) was used to verify that the inhibitory mechanism of CGA on EMT was associated with activating autophagy. Our results found that 60 mg/kg of CGA treatment significantly ameliorated lung inflammation and fibrosis in mice with BLM-induced PF. Besides, CGA inhibited EMT and promoted autophagy in mice with PF. In vitro studies also demonstrated that 50 µM of CGA treatment inhibited EMT and induced autophagy related factors in TGF-β1-induced EMT cell model. Moreover, the inhibitory effect of CGA on autophagy and EMT in vitro was abolished after using autophagy inhibitor. In conclusion, CGA could inhibit EMT to treat BLM-induced PF in mice through, activating autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisMiceAnimalsChlorogenic AcidEpithelial-Mesenchymal TransitionTransforming Growth Factor beta1Epithelial CellsAutophagyBleomycin

Stichwörter der Autor:innen

anti-fibrotic effectautophagychlorogenic acidepithelial–mesenchymal transitionpulmonary fibrosis

Substanzen

Chlorogenic AcidTransforming Growth Factor beta1Bleomycin

Autor:innen und Institutionen

  • The Sixth People's Hospital of Nantong.

Zitieren

APA

Mao, X., Xie, X., Ma, J., Wei, Y., Huang, Z., Wang, T., Zhu, J., Wang, Y., Zhao, H., & Hua, J. (2023). Chlorogenic Acid Inhibited Epithelial–Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00071

Vancouver

Mao X, Xie X, Ma J, Wei Y, Huang Z, Wang T, et al. Chlorogenic Acid Inhibited Epithelial–Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b23-00071

BibTeX
@article{Mao2023,
  author = {Mao, Xiaojuan and Xie, Xiaomin and Ma, Jun and Wei, Yulin and Huang, Zhiyong and Wang, Tiantian and Zhu, Jiaqi and Wang, Yue and Zhao, Huan and Hua, Jiajia},
  title = {Chlorogenic Acid Inhibited Epithelial–Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/bpb.b23-00071}
}
Kostenlos starten →